Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 11/12/2024Abbisco Reports Positive Top-line Results from Pivotal Phase 3 MANEUVE...
  • 11/11/2024Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC Tre...
  • 11/11/2024China Approves Second KRAS-G12C Inhibitor, Garsorasib, Co-developed by...
  • 11/11/2024Precision Bio's CD19-Targeted CAR-T Therapy, pCAR-19B, Selected for Or...
  • 11/11/2024Alphamab Reports Results of FIH Clinical Study of Anti-HER2 ADC and PD...
  • 11/8/2024Junshi Reports on Phase II Trial of Toripalimab in Combo with Gemcitab...
  • 11/8/2024Takeda Initiates Phase 3 Trials in China for Sleep Disorder Drug TAK-8...
  • 11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...
  • 11/7/2024AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designation...
  • 11/7/2024CStone Announces Patent Publication for First-in-Class ADC CS5006
  • 11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...
  • 11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas
  • 11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...
  • 11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval
  • 11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA
  • 11/4/2024Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...
  • 11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...
  • 11/4/2024CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses
  • 10/31/2024CirCode Advances Gene Therapy with HM2002 IND Approval
  • 10/31/2024AllianThera's IND for IBD Candidate ATB102 Cleared by the USFDA
  • 10/31/2024CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...
  • 10/30/2024Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...
  • 10/30/2024Innovent Announces Positive Phase 2 Results for Picankibart in Psorias...
  • 10/29/2024Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...
  • 10/28/2024NiKang Presents Discovery of NKT3964, a FIC, Highly Potent and Selecti...
  • 10/28/2024CSPC's BCMA-targeted mRNA-LNP-Based CAR-T SYS6020 Secures New Clinical...
  • 10/28/2024CORXEL and LENZ Therapeutics Announce Positive Topline Data from China...
  • 10/28/2024Beihai Biotech's BEIZRAY® (BH009) Receives FDA Approval for Multiple ...
  • 10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...
  • 10/24/2024CASI Granted Chinese CTA Approval for CID-103 in Immune Thrombocytope...
  • Page:8/11 Total number of articles:323: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group